ROBERTS 063 (Agrylin 0.5 mg)
Generic Name: anagrelide
Pill with imprint ROBERTS 063 is White, Capsule-shape and has been identified as Agrylin 0.5 mg. It is supplied by Shire US Inc.
Agrylin is used in the treatment of thrombocythemia; chronic myelogenous leukemia and belongs to the drug class miscellaneous coagulation modifiers. Risk cannot be ruled out during pregnancy. Agrylin 0.5 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ROBERTS 063
Agrylin
- Generic Name:
- anagrelide
- Imprint:
- ROBERTS 063
- Strength:
- 0.5 mg
- Color:
- White
- Shape:
- Capsule-shape
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous coagulation modifiers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Shire US Inc
- National Drug Code (NDC):
- 54092-0063
More about Agrylin (anagrelide)
- Agrylin Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews
- Generic Availability
- Drug class: miscellaneous coagulation modifiers
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
